open access
Selected pathogen inactivation topics presented during the 27th Regional Congress of the International Society of Blood Transfusion in Copenhagen (17–21 June 2017)
open access
Abstract
xx
Abstract
xx
Keywords
Selected pathogen inactivation
About this articleTitle
Selected pathogen inactivation topics presented during the 27th Regional Congress of the International Society of Blood Transfusion in Copenhagen (17–21 June 2017)
Journal
Journal of Transfusion Medicine
Issue
Article type
Conference report / Report
Pages
107-111
Published online
2017-10-25
Bibliographic record
Journal of Transfusion Medicine 2017;10(3):107-111.
Keywords
Selected pathogen inactivation
Authors
Elżbieta Lachert
Jolanta Antoniewicz-Papis
References (11)- Dimberg LY, Doane S, Yonemura S, et al. Quallity of red blood cells derived from whole blood treated with UV light and riboflavin. Vox Sanguinis. 2017; 112(Suppl.1): P–248.
- Dimberg LY, Doane S, Hovenga N, et al. and Marschner S: Quality of whole blood treated with UV light and riboflavin after 24 H in room temperature. Vox Sanguinis. 2017; 112(Suppl.1): P–249.
- Taha M, Culibrk B, Schubert P, et al. and Ramirez-Arcos S: Inactivation of biofilm –derived staphylococcus epidermidis in platelet concentrates with riboflavin and staphylococcus epidermidis in platelet concentrates with riboflavin and ultraviolet light treatment. Vox Sanguinis. 2017; 112(Suppl.1): P–252.
- Yonemura S, Doane S, Gosney J, et al. Assessment of cell quality following riboflavin and ultraviolet light treatment of whole blood in citrate-phosphate-dextrose-adenine anticoagulant. Vox Sanguinis. 2017; 112(Suppl.1): P–264.
- Yonemura S, Doane S, Gilmour D, et al. Assessment of pathogen reduction capacity following riboflavin and ultraviolet light treatment of whole blood in citrate-phosphate-dextrose-adenine anticoagulant. Vox Sanguinis. 2017; 112(Suppl.1): P–265.
- Lachert E, Kubis J, Antoniewicz-Papis J, Rosiek A, Mikolowska A, and Letowska M. Pathogen inactivations systems in Polish Blood Transfusion Centers in 2012–2015. Vox Sanguinis 2017, 112, (Suppl.1), P-268.
- Jimenez-Marco T, Garcia-Recio M, Bautista-Gili A, et al. Riboflavin and UV light treated platelets ensure an adequate transfusion dose, similar to untreated platelets. Vox Sanguinis. 2017; 112(Suppl.1): P–271.
- Gravemann U, Handke W, Sumian C, et al. Influence of the temperature on the quality and virus inactivation capacity of methylene-blue treated plasma using the Theraflex MB-plasma System. Vox Sanguinis. 2017; 112(Suppl.1): P–257.
- Gravemann SU, Tolksdorf F, Handke W. Culler and Seltsam A: Effectiveness of the THERAFLEX UV-PLATELETS technology against clinically relevant transfusion – transmited bacteria strains. Vox Sanguinis. 2017; 112(Suppl.1): P–251.
- Brixner V, Dombos S, Weber I, et al. In vitro assessment of untreated, UVC-treated and gamma-irradiated plasma reduced platelet concentrates prepared from thrombapheresis under routine conditions. Vox Sanguinis. 2017; 112(Suppl.1): P–253.
- Marks DC, Fryk J, Hobson-Peters J, et al. Zika virus infectivity is reduced following treatment with the Theraflex UVC-Platelets and Theraflex MB-Plasma Systems. Vox Sanguinis. 2017; 112(Suppl.1): P–258.